Projects

IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.

Keywords

Research group

Researcher

From date

To date

Caracterización y rehabilitación de condición post COVID-19 en población pediátrica

Project status

Ongoing

Start/End

2023

/

2028

Principal investigator

Sara Morón López

External researchers

Carlos Gonzalo de Liria,

Maria Méndez Hernández,

Èlia Domènech,

Alba González-Aumatell,

Clara Carreras-Abad

Participating entities

IrsiCaixa, IGTP

Strategic lines

Global infectious diseases

Financing entity

Philanthropy

Reference

LC2313

Personal investigador col·laborador d'IrsiCaixa: Jon Izquierdo Pujol, Javier Martínez Picado, Judith Dalmau Moreno, Victor Urrea Gales, Lidia Garrido Sanz.
Multi-OMICS identification and validation of mechanisms triggered by immune interventions aimed at reducing the size of the replication competent reservoir

Project status

Ongoing

Start/End

2023

/

2028

Principal investigator

Javier Martínez-Picado

External researchers

Linos Vandekerckhove,

Ashish Arunkumar Sharma,

Rafick Sekaly

Participating entities

IrsiCaixa, Ghent University, Emory

Strategic lines

Global infectious diseases

Financing entity

National Institutes of Health (NIH)

Reference

1P01AI178376-01
Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccination

Project status

Ongoing

Start/End

2023

/

2028

Principal investigator

Christian Brander

External researchers

Dennis Hartigan-O'Connor

Participating entities

IrsiCaixa, The Regents of the University of California

Strategic lines

Global infectious diseases

Financing entity

National Institutes of Health (NIH)

Reference

P01AI178375
Desarrollo de una vacuna contra el VIH-1 basada en regiones de vulnerabilidad de la envuelta altamente conservadas con vías de administración mejoradas

Project status

Ongoing

Start/End

2023

/

2026

Principal investigator

Jorge Carrillo Molina

Participating entities

IrsiCaixa

Strategic lines

Global infectious diseases

Financing entity

Ministerio de Ciencia, Innovación y Universidades

Reference

PID2022-139831OB-I00

IrsiCaixa collaborator researchers: Mª Luisa Rodríguez de la Concepción, Núria Pedreño López, Erola Ainsua Enrich.
Análisis de los mecanismos endocíticos desencadenados por CD169 en células mieloides y su contribución a la diseminación viral

Project status

Ongoing

Start/End

2023

/

2026

Principal investigator

Javier Martínez-Picado

Patricia Resa Infante

Participating entities

IrsiCaixa

Strategic lines

Global infectious diseases

Financing entity

Ministerio de Ciencia, Innovación y Universidades

Reference

PID2022-139271OB-I00

IrsiCaixa collaborator researchers: Itziar Erkizia Jauregi, Patricia Piñol Jurado, Jakub Chojnacki, Fernando Laguía Nueda
Tumor-specific neoantigens as targets for personalized vaccines

Project status

Ongoing

Start/End

2022

/

2024

Principal investigator

Núria de la Iglesia Zaragoza

Participating entities

IrsiCaixa, ICO, Hospital Germans Trias i Pujol, CNAG-CRG

Strategic lines

Cancer

Financing entity

Instituto de Salud Carlos III

Reference

PI21/01652

IrsiCaixa collaborative researchers: Gustavo Rodríguez Esteban, Anna López Plana

External collaborative researchers: Rafael Villanueva, Laura Layos, Holger Heyn
Role of NK cells in post COVID-19 condition (LoNK-COVID)

Project status

Ongoing

Start/End

2022

/

2025

Principal investigator

Maria Nevot Banús

Strategic lines

Immunopathology

Financing entity

Ministerio de Ciencia, Innovación y Universidades

Reference

PID2021-124226OB-100
Impact of HIV envelope function and antigenicity on elite control of HIV replication

Project status

Ongoing

Start/End

2021

/

2023

Principal investigator

Julià Blanco Arbués

Participating entities

IrsiCaixa AIDS Research Institute, ISCII, Institut de Recerca Germans Trias i Pujol

Strategic lines

Immunopathology

Financing entity

ISCIII
EU Research Scholars Program in HIV

Project status

Ongoing

Start/End

2021

/

2023

Principal investigator

Sara Morón López

Participating entities

IrsiCaixa

Strategic lines

Global infectious diseases

Financing entity

GILEAD
Discovery of novel inhibitors of HIV-1 RNA biogenesis based on the inhibition of the ribonucleoprotein RRE-Rev

Project status

Ongoing

Start/End

2021

/

2024

Principal investigator

Javier Martínez-Picado

External researchers

José Alcamí, Vicente Marchán

Participating entities

IrsiCaixa, ISCIII, University of Barcelona, Catholic University of Valencia

Strategic lines

Therapies and vaccines